BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33165094)

  • 21. Malignant teratoid medulloepithelioma with retinoblastic and rhabdomyoblastic differentiation.
    Earl JB; Minckler DS; Lee TC; Murphree AL
    J AAPOS; 2013 Jun; 17(3):328-31. PubMed ID: 23791415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
    Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
    Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Better visualization of retinoblastoma metastases with Tc-99m sestamibi versus Tl-201.
    Aktolun C; Bayhan H; Ozturk E
    Clin Nucl Med; 1995 May; 20(5):446-8. PubMed ID: 7628151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.
    Racher H; Soliman S; Argiropoulos B; Chan HS; Gallie BL; Perrier R; Matevski D; Rushlow D; Piovesan B; Shaikh F; MacDonald H; Corson TW
    Cancer Genet; 2016; 209(7-8):359-63. PubMed ID: 27318443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
    Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
    Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of S-100 protein immunoreactivity in normal human retina and retinoblastoma.
    Karim MM; Itoh H
    Ophthalmologica; 1997; 211(6):351-3. PubMed ID: 9380352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
    Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
    Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoblastoma in an adult: case report and literature review.
    Odashiro AN; Pereira PR; de Souza Filho JP; Cruess SR; Burnier MN
    Can J Ophthalmol; 2005 Apr; 40(2):188-91. PubMed ID: 16049534
    [No Abstract]   [Full Text] [Related]  

  • 29. Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases.
    Fanburg-Smith JC; Hengge M; Hengge UR; Smith JS; Miettinen M
    Ann Diagn Pathol; 1998 Dec; 2(6):351-62. PubMed ID: 9930572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is CRX protein a useful marker in differential diagnosis of tumors of the pineal region?
    Manila A; Mariangela N; Libero L; Francesca G; Romana BF; Felice G
    Pediatr Dev Pathol; 2014; 17(2):85-8. PubMed ID: 24555912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.
    Ozdemir H; Tacyildiz N; Unal E; Yavuz G; Ugur H; Gunduz K
    Pediatr Hematol Oncol; 2007; 24(3):221-31. PubMed ID: 17454793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
    Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
    Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
    Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
    Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Workup for metastatic retinoblastoma. A review of 261 patients.
    Karcioglu ZA; al-Mesfer SA; Abboud E; Jabak MH; Mullaney PB
    Ophthalmology; 1997 Feb; 104(2):307-12. PubMed ID: 9052637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging.
    Bakhshi S; Meel R; Kashyap S; Sharma S
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):e182-5. PubMed ID: 21364467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Fas ligand in retinoblastoma.
    Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
    Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
    Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
    Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
    [No Abstract]   [Full Text] [Related]  

  • 40. Metastatic retinoblastoma: single institution experience over two decades.
    Cozza R; De Ioris MA; Ilari I; Devito R; Fidani P; De Sio L; Demelas F; Romanzo A; Donfrancesco A
    Br J Ophthalmol; 2009 Sep; 93(9):1163-6. PubMed ID: 19556217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.